← Leaderboards
Michael J Sailor
University Of California, San Diego
$3,905,383
Attributed
$7,195,387
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,695,387 · 4
FDA$500,000 · 1
By mechanism
R01$6,599,024 · 2
U01$500,000 · 1
P41$96,363 · 2
Top collaborators
- Sangeeta N. Bhatia5 shared
- William R. Freeman3 shared
- Erkki I Ruoslahti3 shared
- Emily Jessica Anglin2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Liangfang Zhang$5,562,722
- Veronica Shubayev$5,703,515
- Dmitri Simberg$8,108,683
- Shaochen Chen$8,013,482
- Victor Nizet$31,303,620
Others in their field
Top investigators on “Silicon”
- Anders Ryd · Cornell University$80,985,944
- Harold G Craighead · Cornell University$39,497,888
- Juan J De Pablo · University Of Wisconsin-Madison$26,844,470
- Robert J Hamers · University Of Wisconsin-Madison$20,723,333
- Harry B Gray · California Institute Of Technology$20,000,000
- Ali Yazdani · University Of Illinois At Urbana-Champaign$19,975,000
Research focus
SiliconNanoparticleUptakeCytotoxicityCellsDrug KineticsPeptidesTreatment EfficacyBacterial InfectionsIn VitroTissuesIn VivoSurfaceInfectionSide EffectBiologicalKineticsLabelInterestSmall Interfering RnaPharmaceutical PreparationsFormulationDosePenetration
Grant awards (14)
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections$649,115
R01 · FY2025 · AI · contact PI
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$413,374
R01 · FY2025 · EY
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections$684,136
R01 · FY2024 · AI · contact PI
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$413,374
R01 · FY2024 · EY
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$423,374
R01 · FY2023 · EY
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$784,101
R01 · FY2021 · AI · contact PI
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$788,842
R01 · FY2020 · AI · contact PI
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$800,521
R01 · FY2019 · AI · contact PI
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$805,479
R01 · FY2018 · AI · contact PI
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$836,708
R01 · FY2017 · AI · contact PI
Modeling of the vitreous for in vitro prediction of drug delivery of porous silicon particles and episcleral plaques$232,279
U01 · FY2015 · FD · contact PI
Modeling of the vitreous for in vitro prediction of drug delivery of porous silicon particles and episcleral plaques$267,721
U01 · FY2014 · FD · contact PI
PHOTOLUMINESCENT POROUS SI FOR BIOLOGICAL APPLICATIONS$41,818
P41 · FY2010 · RR · contact PI
PHOTOLUMINESCENT POROUS SI FOR BIOLOGICAL APPLICATIONS$54,545
P41 · FY2009 · RR · contact PI